47.41
Alkermes Plc (ALKS) 最新ニュース
Alkermes PLC (ALKS) Shares Fall 4.4% -- What GF Score of 64 Tells Investors - GuruFocus
Alkermes ends Amneal VIVITROL supply pact without penalties - scanx.trade
Alkermes reports phase 2 Vibrance-2 data; alixorexton meets dual primary endpoints in narcolepsy type 2 - scanx.trade
Alkermes (ALKS) Shares: Posts a 3.31% Loss to $48.52 for the Current Session; Current Setup: Traders Can Monitor the $46.09-$50.95 Range for the Current SessionStatistical Arbitrage - vinanet.vn
Q2 2026 Alkermes Plc Earnings Call Transcript - GuruFocus
Empowered Funds LLC Sells 53,381 Shares of Alkermes plc $ALKS - MarketBeat
STU:8AK EV-to-OCF: 37.38 — 44% Above Median - GuruFocus
Alkermes (ALKS) SVP, Chief Commercial Officer Christian Nichols Sells 7,576 Shares - GuruFocus
Alkermes (NASDAQ:ALKS) SVP Sells $372,966.48 in Stock - MarketBeat
Alkermes (NASDAQ: ALKS) holder to sell 7,576 shares worth $373K - Stock Titan
Alkermes (ALKS) Advances 1.53% as Shares Hold Firm Above Key SupportVOLD Alert - Vinanet
Alkermes Plc (ALKS) Stock Analysis: A Look At The 14.15% Potential Upside - DirectorsTalk Interviews
Alkermes (ALKS) Eases to $49.06: Key Levels to Watch After 0.79% DipPrice Target - Vinanet
S&CO Inc. Takes Position in Alkermes plc $ALKS - MarketBeat
Alkermes PLC (ALKS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
ALKS Stock Surges 15% On Lilly-Centessa Buyout Igniting Sleep Pipeline Hopes - Stocktwits
Alkermes plc $ALKS Stock Position Trimmed by Empowered Funds LLC - MarketBeat
Quantinno Capital Management LP Grows Holdings in Alkermes plc $ALKS - MarketBeat
Bank of America Corp DE Trims Position in Alkermes plc $ALKS - MarketBeat
ALKS Stock Rises 27% in 3 Months: Here's What You Should Know - TradingView
Alkermes Lowers Interest Rate Spreads with Amendment to Credit Agreement - Kalkine Media
Alkermes amends credit agreement to reduce interest rates on term loans - Investing.com Nigeria
Form 8K Alkermes plc. For: 12 August By Investing.com - Investing.com Canada
Alkermes Reduces Spreads on $1.52 Billion Term Loans by Up to 75 bps - TradingView
Alkermes (NASDAQ: ALKS) lowers interest spreads on large term loan A and B debt - Stock Titan
Alkermes plc Enters into Amendment to Credit Agreement Reducing Interest Rate Spread on Term Loan Facilities - marketscreener.com
Hennion & Walsh Asset Management Inc. Makes New Investment in Alkermes plc $ALKS - MarketBeat
Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure? - Yahoo Finance
Alkermes plc (ALKS) Stock Analysis: Evaluating a 13.89% Upside in the Biopharmaceutical Sector - DirectorsTalk Interviews
Alkermes Plc (ALKS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Did Alkermes’ (ALKS) Profit Slide and Cash-Conserving Moves Just Shift Its Investment Narrative? - simplywall.st
The Manufacturers Life Insurance Company Sells 42,319 Shares of Alkermes plc $ALKS - MarketBeat
Royal Bank of Canada Sells 21,159 Shares of Alkermes plc $ALKS - MarketBeat
(ALKS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Amundi Increases Stake in Alkermes plc $ALKS - MarketBeat
Alkermes plc $ALKS Shares Acquired by California State Teachers Retirement System - MarketBeat
Sei Investments Co. Has $5.44 Million Stake in Alkermes plc $ALKS - MarketBeat
Major Decision: Nancy Snyderman Exercises Options, Realizing $116K At Alkermes - Benzinga
Alkermes Insider Sold Shares Worth $2,239,076, According to a Recent SEC Filing - marketscreener.com
Form 4 Alkermes plc. For: 3 August By Investing.com - Investing.com South Africa
Alkermes Plc (ALKS) Stock Analysis: A Compelling 14% Upside Potential For Investors - DirectorsTalk Interviews
Research Analysts Set Expectations for Alkermes Q3 Earnings - MarketBeat
Seven Fleet Capital Management LP Acquires New Shares in Alkermes plc $ALKS - MarketBeat
Why Alkermes (ALKS) Is Down 7.4% After Q2 Profit Drop And New Equity Shelf Filing - simplywall.st
Is Alkermes (ALKS) Priced For Orexin Success Or Too Rich? - Yahoo Finance
Alkermes plc 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ALKS) 2026-07-31 - Seeking Alpha
H.C. Wainwright reiterates Neutral stock rating on Alkermes - Investing.com
Stempoint Capital LP Acquires Shares of 80,492 Alkermes plc $ALKS - MarketBeat
Alkermes Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says - marketscreener.com
Entropy Technologies LP Sells 40,839 Shares of Alkermes plc $ALKS - MarketBeat
Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down - The Globe and Mail
ALKS: Strong Q2 revenue, robust orexin pipeline progress, and LUMRYZ integration drive growth - TradingView
Piper Sandler raises Alkermes stock price target on pipeline value - Investing.com
Alkermes Q2 Earnings Call Highlights - Yahoo Finance
Alkermes Q2 2026 slides: revenue surges 27% but acquisition costs squeeze - Investing.com
Earnings call transcript: Alkermes tops Q2 2026 estimates but shares fall premarket - Investing.com
Alkermes plc Revenue Breakdown – NASDAQ:ALKS - TradingView
ALKS Looks 64.8% Overvalued on GF Value™ - GuruFocus
Alkermes plc. Q2 2026: Revenue $496M, EPS $0— 10-Q Summary - TradingView
Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Avadel deal pushes Alkermes (NASDAQ: ALKS) to H1 2026 net loss - Stock Titan
Why is Alkermes stock sliding today? - Investing.com
Piper Sandler raises Alkermes stock price target on pipeline value By Investing.com - Investing.com Canada
Is Alkermes PLC (ALKS) Overvalued After Q2 Earnings Beat Expecta - GuruFocus
Alkermes affirms FY26 sales guidance of $1.730B-$1.840B - scanx.trade
ALKS Looks 64.8% Overvalued on GF Value™ as Insider Selling Pers - GuruFocus
Alkermes (ALKS) Reports Break-Even Earnings for Q2 - Yahoo Finance
大文字化:
|
ボリューム (24 時間):